Clinical Report: Antibiotic Prescribing Patterns for Pharyngitis in Saudi Arabia
Overview
This study reveals that antibiotics were prescribed in 84.7% of acute pharyngitis visits in Saudi Arabia, with significant associations found between prescribing patterns and patient age and health insurance type. The findings highlight the urgent need for improved antibiotic stewardship in primary care settings.
Background
Inappropriate antibiotic prescribing for conditions like acute pharyngitis contributes to the growing problem of antibiotic resistance, which poses a significant public health threat. Understanding the factors influencing prescribing patterns is crucial for developing effective interventions. This study focuses on the role of demographic characteristics and health insurance in antibiotic prescribing in Saudi Arabian primary care.
Data Highlights
Metric
Value
Antibiotic prescription rate
84.7%
Amoxicillin prescriptions
62%
Azithromycin prescriptions
37%
Increased likelihood of prescription (government insurance)
28.6%
Key Findings
Antibiotics were prescribed in 84.7% of acute pharyngitis visits.
Amoxicillin and azithromycin accounted for 62% and 37% of prescriptions, respectively.
Children aged 0–7 years had higher odds of receiving antibiotics.
Patients with governmental insurance were 28.6% more likely to receive antibiotics compared to those with private insurance.
Gender did not significantly influence antibiotic prescribing patterns.
Clinical Implications
Healthcare providers should be aware of the high rates of antibiotic prescribing for acute pharyngitis and consider patient age and insurance status when making prescribing decisions. Strengthening antibiotic stewardship programs is essential to ensure adherence to clinical guidelines and reduce unnecessary antibiotic use.
Conclusion
The study underscores the need for targeted interventions to optimize antibiotic prescribing practices in primary care settings, particularly in relation to patient demographics and health insurance factors.
Analysis of England’s multicancer early detection screening trial found modest, temporary diagnostic delays in participating regions, adding to concerns about health system effects and the evidence base for population-level blood-based cancer screening.
